Biolife Solutions Inc
BLFS- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000834365
No open-market purchases or sales by Biolife Solutions Inc insiders were filed in the last 90 days; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Biolife Solutions Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Biolife Solutions Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Berard Todd | Chief Marketing Officer | 161,823 | Sep 22, 2026 | 13 |
| Mathew Aby J. | EVP & Chief Scientific Officer | 387,269 | Sep 22, 2026 | 13 |
| Werner Sean | Chief Technology Officer | 47,135 | Sep 22, 2026 | 8 |
| De Greef Roderick | President and CEO | 728,196 | Sep 22, 2026 | 6 |
| Wichterman Troy | Chief Financial Officer | 211,286 | Sep 22, 2026 | 14 |
| Casdin Partners GP, LLC | 10% Owner | 4,757,165Indirect | May 21, 2026 | 2 |
| Casdin Capital, LLC | 10% Owner | 4,757,165Indirect | May 21, 2026 | 2 |
| Casdin Eli | 10% Owner | 4,757,165Indirect | May 21, 2026 | 2 |
| Casdin Partners Master Fund, L.P. | 10% Owner | 4,757,165Indirect | May 21, 2026 | 2 |
| Foster Karen A. | Chief Quality and Operations | 108,758 | Mar 31, 2026 | 9 |
| Aebersold Sarah | Chief Human Resources Officer | 92,429 | Mar 23, 2026 | 7 |
| Goswami Joydeep | Director | 53,156 | Feb 26, 2026 | 3 |
| Ellingson Rachel | Director | 57,995 | Feb 26, 2026 | 1 |
| Hunt Anthony | Director | 15,046 | Feb 26, 2026 | 1 |
| Moore Timothy L. | Director | 44,943 | Feb 26, 2026 | 1 |
| Coste Catherine | Director | 13,871 | Feb 26, 2026 | 1 |
| DuRoss Amy | Director | 26,857 | Feb 26, 2026 | 4 |
| Richardson Garrie | Chief Revenue Officer | 114,773 | Sep 18, 2024 | 0 |
| Schick Joseph C | Director | 43,953 | Mar 12, 2024 | 0 |
| Phillips Geraint | SVP, Global Operations | 65,998 | Mar 12, 2024 | 0 |
| Rice Michael | Other: Former CEO and Director | 347,085 | Nov 1, 2023 | 0 |
| Schulz Marcus | Chief Revenue Officer | 42,097 | Aug 29, 2023 | 0 |
| Hinson Andrew G | Director | 17,675 | Aug 18, 2021 | 0 |
| Cohen Raymond W | Director | 27,763 | Jul 14, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Foster Karen A.Chief Quality Officer | SSale | −16.3K | $45.24 | −$738.9K | −18.3%72.8K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Schulz MarcusChief Revenue Officer | SSale | −4.92K | $45.65 | −$224.6K | −13.5%31.4K after | 2 lots |
| Jul 22, 2021 (view filing) | Jul 20 | 2 days | Schulz MarcusChief Revenue Officer | SSale | −2.54K | $45.10 | −$114.5K | −6.5%36.4K after | |
| Jul 22, 2021 (view filing) | Jul 20 | 2 days | Aebersold SarahVP, Global Human Resources | SSale | −1.06K | $45.10 | −$47.8K | −5.1%19.8K after | |
| Jul 21, 2021 (view filing) | Jul 19-21 | 2 days | Mathew Aby J.Exec VP & Chief Scientific Off | SSale | −18.9K | $44.68 | −$842.3K | −8.3%209.6K after | 2 lots |
| Jul 19, 2021 (view filing) | Jul 15-16 | 4 days | Berard ToddChief Marketing Officer | SSale | −12.3K | $43.39 | −$534.8K | −13.5%79.1K after | 2 lots |
| Jul 16, 2021 (view filing) | Jul 15 | 1 day | Hinson Andrew GDirector | SSale | −2.50K | $44.44 | −$111.1K | −11.0%20.2K after | |
| Jul 9, 2021 (view filing) | Jul 8 | 1 day | Schulz MarcusChief Revenue Officer | SSale | −240 | $45.73 | −$11.0K | −0.6%38.9K after | 2 lots |
| Jul 8, 2021 (view filing) | Jul 6-8 | 2 days | Rice MichaelCEO | SSale | −22.9K | $46.21 | −$1.06M | −7.8%269.3K after | 2 lots |
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Mathew Aby J.Exec VP & Chief Scientific Off | SSale | −715 | $43.75 | −$31.3K | −0.3%209.6K after | |
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Foster Karen A.Chief Quality Officer | SSale | −607 | $43.75 | −$26.6K | −0.8%72.8K after | |
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Rice MichaelCEO | SSale | −902 | $43.75 | −$39.5K | −0.3%269.3K after | |
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | De Greef RoderickCFO | SSale | −685 | $43.75 | −$30.0K | −0.4%174.9K after | |
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Berard ToddChief Marketing Officer | SSale | −502 | $43.75 | −$22.0K | −0.6%79.1K after |